Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.22 to a profit $1.21. For the current year, the average estimate is a profit of $5.05, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Teva Pharmaceutical Industries Limited has been performing on an annual basis: